| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $23,093 ) |
| | 2024 | 2024 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44AG065039 | Whole blood filter paper assay for Alzheimers Disease | 001 | 2 | NIH | 4/22/2024 | $23,093 |
| | 2024 | 2023 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44AG065039 | Whole blood filter paper assay for Alzheimers Disease | 000 | 2 | NIH | 10/11/2023 | $0 |
| | 2024 | 2021 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43GM140771 | TempO-LINC high throughput, high sensitivity single cell gene expression profiling assay | 000 | 1 | NIH | 1/12/2024 | $0 |
| | 2024 | 2021 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 000 | 3 | NIH | 1/3/2024 | $0 |
| | 2024 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43HL154878 | TempO-Vseq Screen for Genomic Risk of CAD Using Blood from a Finger Prick | 000 | 1 | NIH | 2/16/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,662,511 ) |
| | 2023 | 2023 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44GM140771 | TempO-LINC high throughput high sensitivity single cell gene expression profiling assay Ph II | 000 | 2 | NIH | 6/22/2023 | $1,241,285 |
| | 2023 | 2023 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44AG065039 | Whole blood filter paper assay for Alzheimers Disease | 000 | 2 | NIH | 9/20/2023 | $1,421,226 |
| | 2023 | 2021 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43ES032514 | TempO-Seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk | 000 | 1 | NIH | 4/6/2023 | $0 |
| | 2023 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 000 | 1 | NIH | 9/20/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43HL154878 | TempO-Vseq Screen for Genomic Risk of CAD Using Blood from a Finger Prick | 000 | 1 | NIH | 6/11/2022 | $0 |
| | 2022 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43ES032368 | Functional Read-Out Enabling High Compound Throughput Toxicokinetic Assays | 000 | 1 | NIH | 8/17/2022 | $0 |
| | 2022 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 000 | 1 | NIH | 10/18/2021 | $0 |
| | 2022 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 001 | 1 | NIH | 6/2/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,113,689 ) |
| | 2021 | 2021 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 000 | 3 | NIH | 8/25/2021 | $476,709 |
| | 2021 | 2021 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43ES032514 | TempO-Seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk | 000 | 1 | NIH | 12/25/2020 | $252,121 |
| | 2021 | 2021 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43GM140771 | TempO-LINC high throughput, high sensitivity single cell gene expression profiling assay | 000 | 1 | NIH | 4/15/2021 | $402,266 |
| | 2021 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 000 | 1 | NIH | 2/16/2021 | $0 |
| | 2021 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R41HG010638 | High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators | 000 | 1 | NIH | 9/8/2021 | -$17,407 |
| | 2021 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 001 | 1 | NIH | 9/24/2021 | $0 |
| | 2021 | 2017 | BIOSPYDER TECHNOLOGIES, INC. | 5928 PASCAL CT STE 100 | CARLSBAD | CA | 92008-8826 | SAN DIEGO | USA | R44HG008917 | TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells | 000 | 2 | NIH | 9/24/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,276,951 ) |
| | 2020 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43ES032368 | Functional Read-Out Enabling High Compound Throughput Toxicokinetic Assays | 000 | 1 | NIH | 8/11/2020 | $224,980 |
| | 2020 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43HL154878 | TempO-Vseq Screen for Genomic Risk of CAD Using Blood from a Finger Prick | 001 | 1 | NIH | 8/17/2020 | $0 |
| | 2020 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43HL154878 | TempO-Vseq Screen for Genomic Risk of CAD Using Blood from a Finger Prick | 000 | 1 | NIH | 7/24/2020 | $409,096 |
| | 2020 | 2020 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 000 | 2 | NIH | 7/20/2020 | $642,875 |
| | 2020 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44ES024107 | TempO-Seq for Preserved Tissues in Toxicity Testing Phase II | 000 | 3 | NIH | 5/17/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $848,520 ) |
| | 2019 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 001 | 1 | NIH | 9/19/2019 | $70,000 |
| | 2019 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 001 | 1 | NIH | 8/3/2019 | -$436,986 |
| | 2019 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 001 | 1 | NIH | 8/3/2019 | $436,986 |
| | 2019 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43AG065039 | Whole Blood Filter Paper Assay for Alzheimers Disease | 000 | 1 | NIH | 7/31/2019 | $436,986 |
| | 2019 | 2019 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R41HG010638 | High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators | 000 | 1 | NIH | 9/6/2019 | $349,024 |
| | 2019 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG007339 | TempO-Seq: A Multiplexed Gene Expression Profiling Platform | 000 | 4 | NIH | 7/2/2019 | $0 |
| | 2019 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 000 | 1 | NIH | 1/3/2019 | $0 |
| | 2019 | 2017 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG008917 | TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells | 000 | 2 | NIH | 9/18/2019 | $0 |
| | 2019 | 2017 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R33CA183688 | RASL-Seq Expression Profiling of FFPE Tissues | 000 | 3 | NIH | 12/11/2018 | -$3,835 |
| | 2019 | 2017 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG007815 | Multiplexed mRNA and miRNA Profiling of Single Cells Phase II | 000 | 3 | NIH | 11/13/2018 | $0 |
| | 2019 | 2017 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG008917 | TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells | 000 | 2 | NIH | 9/18/2019 | $0 |
| | 2019 | 2015 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43HG008245 | RASL-Seq CTC Assay | 000 | 2 | NIH | 10/23/2018 | -$3,655 |
|
| Issue Date FY: 2018 ( Subtotal = $1,698,953 ) |
| | 2018 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG008917 | TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells | 000 | 2 | NIH | 9/24/2018 | $393,864 |
| | 2018 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG009763 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications | 000 | 1 | NIH | 9/17/2018 | $223,532 |
| | 2018 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44ES024107 | TempO-Seq for Preserved Tissues in Toxicity Testing Phase II | 000 | 3 | NIH | 6/22/2018 | $505,295 |
| | 2018 | 2018 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R44HG007339 | TempO-Seq: A Multiplexed Gene Expression Profiling Platform | 000 | 4 | NIH | 2/23/2018 | $576,262 |
| | 2018 | 2015 | BIOSPYDER TECHNOLOGIES, INC. | 5922 FARNSWORTH CT STE 102 | CARLSBAD | CA | 92008-7398 | SAN DIEGO | USA | R43HG008245 | RASL-Seq CTC Assay | 000 | 2 | NIH | 5/24/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $4,993,441 ) (Continued on the next page) |
|
